EGFR expression is abnormally elevated and closely associated with malignant behaviors such as tumor growth, invasion, and metastasis in NSCLC, thereby becoming a crucial target for targeted therapy (To et al., 2019). This evidence concerns the gene EGFR and non-small cell lung carcinoma.